Photodynamic and Sonodynamic Therapy Synergy: Mechanistic Insights and Cellular Responses Against Glioblastoma Multiforme DOI
Swati Sharma,

Geetanjali B. Gone,

Parikshit Roychowdhury

и другие.

Journal of drug targeting, Год журнала: 2024, Номер unknown, С. 1 - 23

Опубликована: Ноя. 18, 2024

Glioblastoma multiforme (GBM), the most aggressive form of brain cancer, poses substantial challenges to effective treatment due its complex and infiltrative nature, making it difficult manage. Photodynamic therapy (PDT) sonodynamic (SDT), have emerged as promising individual options against GBM their least-invasive approach. However, both PDT SDT drawbacks that require careful consideration. A combination using light sound waves has gained attention, offering new avenues overcome from therapies. Sono-photodynamic (SPDT) been used various tumors. Researchers are considering SPDT a favorable alternative conventional therapies for GBM. offers complementary mechanisms action, including production ROS, disruption cellular structures, induction apoptosis, leading enhanced tumor cell death. This review gives an insight about PDT/SDT limitations in need therapy. We try unveil process explore mechanism behind improved SPDT-meditated death cells by focusing on ROS-mediated response occurring result discussing current modifications existing sensitizers optimal use

Язык: Английский

Therapeutic Potential of NF-κB Inhibition in Glioblastoma: Gene Therapy Approach with rAAV-5 Mediated IκBαM Overexpression DOI

Ceera Manikandan,

Amit Kumar Jaiswal

Molecular Biotechnology, Год журнала: 2025, Номер unknown

Опубликована: Март 26, 2025

Язык: Английский

Процитировано

0

HDAC6-Activatable Multifunctional Near-Infrared Probe for Glioma Cell Detection and Elimination DOI
Wenyu Wei, Chen Huang, Jie Zhang

и другие.

Analytical Chemistry, Год журнала: 2024, Номер 96(6), С. 2406 - 2414

Опубликована: Фев. 3, 2024

Glioblastoma multiforme (GBM) is a highly aggressive primary brain tumor associated with limited treatment options and high drug resistance, presenting significant challenges in the pursuit of effective strategies. Epigenetic modifications have emerged as promising diagnostic biomarkers therapeutic targets for GBM. For instance, histone deacetylase 6 (HDAC6) has been identified potential pharmacological target Furthermore, overexpression monoamine oxidase A (MAO A) glioma linked to progression, making it an attractive therapy. In this study, we successfully engineered HDAC-MB, activatable multifunctional small-molecule probe goal efficiently detecting killing cells. HDAC-MB can be selectively activated by HDAC6, leading "turn on" near-infrared fluorescence inhibition MAO A, along potent photodynamic therapy (PDT) effects. Consequently, not only enables imaging HDAC6 live cells but also exhibits synergistic effect PDT, effectively inhibiting invasion inducing cellular apoptosis. The distinctive combination features displayed positions versatile tool accurate diagnosis This opens up opportunities enhance outcomes explore future applications theranostics.

Язык: Английский

Процитировано

4

Understanding the Role of Endothelial Cells in Glioblastoma: Mechanisms and Novel Treatments DOI Open Access
Gabrielle Hovis, Neha Chandra,

Nidhi Kejriwal

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(11), С. 6118 - 6118

Опубликована: Июнь 1, 2024

Glioblastoma is a highly aggressive neoplasm and the most common primary malignant brain tumor. Endothelial tissue plays critical role in glioblastoma growth progression, facilitating angiogenesis, cellular communication, tumorigenesis. In this review, we present an up-to-date comprehensive summary of endothelial cells glioblastomas, along with overview recent developments therapies tumor marker identification.

Язык: Английский

Процитировано

4

The prognostic effect of mechanical, ultrastructural, and ECM signatures in glioblastoma core and rim DOI Creative Commons

Bradley Mahaffey,

Zachary P. Fowler,

Zoe Lung

и другие.

APL Bioengineering, Год журнала: 2024, Номер 8(3)

Опубликована: Июнь 24, 2024

Glioblastoma (GBM) is a highly invasive, aggressive brain cancer that carries median survival of 15 months and resistant to standard therapeutics. Recent studies have demonstrated intratumoral heterogeneity plays critical role in promoting resistance by mediating tumor adaptation through microenvironmental cues. GBM can be separated into two distinct regions—a core rim, which are thought drive specific aspects evolution. These differences progression regulated the diverse biomolecular biophysical signals these regions, but acellular characteristics remain poorly described. This study investigates mechanical ultrastructural extracellular matrix (ECM) patient-matched rim tissues. Seven samples one non-neoplastic control were analyzed using atomic force microscopy, scanning electron immunofluorescence imaging quantify mechanical, ultrastructural, ECM composition changes. The results reveal significant parameters between core, stiffer, denser, rich proteins hyaluronic acid tenascin-C when compared alterations intimately related prognostic effect with stiff, dense tissue correlating longer progression-free survival. findings new insights spatial microenvironment identify set may correlate patient prognosis. In long term, aid development strategies combat therapeutic resistance.

Язык: Английский

Процитировано

4

Photodynamic and Sonodynamic Therapy Synergy: Mechanistic Insights and Cellular Responses Against Glioblastoma Multiforme DOI
Swati Sharma,

Geetanjali B. Gone,

Parikshit Roychowdhury

и другие.

Journal of drug targeting, Год журнала: 2024, Номер unknown, С. 1 - 23

Опубликована: Ноя. 18, 2024

Glioblastoma multiforme (GBM), the most aggressive form of brain cancer, poses substantial challenges to effective treatment due its complex and infiltrative nature, making it difficult manage. Photodynamic therapy (PDT) sonodynamic (SDT), have emerged as promising individual options against GBM their least-invasive approach. However, both PDT SDT drawbacks that require careful consideration. A combination using light sound waves has gained attention, offering new avenues overcome from therapies. Sono-photodynamic (SPDT) been used various tumors. Researchers are considering SPDT a favorable alternative conventional therapies for GBM. offers complementary mechanisms action, including production ROS, disruption cellular structures, induction apoptosis, leading enhanced tumor cell death. This review gives an insight about PDT/SDT limitations in need therapy. We try unveil process explore mechanism behind improved SPDT-meditated death cells by focusing on ROS-mediated response occurring result discussing current modifications existing sensitizers optimal use

Язык: Английский

Процитировано

4